Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F19%3A00077799" target="_blank" >RIV/00023001:_____/19:00077799 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11310/19:10397506
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25388" target="_blank" >https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25388</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/jmv.25388" target="_blank" >10.1002/jmv.25388</a>
Alternative languages
Result language
angličtina
Original language name
Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population
Original language description
Active infection with BK polyomavirus (BKPyV) may cause serious complications in transplantation settings. Recently, the level of BKPyV IgG seroreactivity in graft donors has been shown to predict viremia and BKPyV-associated nephropathy in kidney transplant (KTx) recipients. Pretransplantation testing of the donor and recipient BKPyV serostatus could, therefore, identify patients at high risk. For the development of serological immunoassays, antibody response to the predominant BKPyV subtypes (BKPyV-I and BKPyV-IV) was studied using virus-like particle (VLP)-based enzyme-linked immunosorbent assay (ELISA). VLPs made from the capsid protein, VP1, derived from BKPyV-I and BKPyV-IV subtypes were produced using a baculovirus expression system and used as antigens. The tests were used for IgG antibody determination in 50 KTx recipients and 111 healthy blood donors. While 87% of samples reacted with mixed BKPyV-I and BKPyV-IV antigens, only 49% of samples were reactive in both ELISA tests when using BKPyV-I or BKPyV-IV antigens separately. Twenty-seven percent of healthy blood donors and 26% of KTx recipients were reactive only with BKPyV-I, while 9% and 20% were reactive only with BKPyV-IV, respectively. To determine the specificities of the antigens, selected seropositive samples were retested after preadsorption with soluble BKPyV-I, BKPyV-IV, or JC polyomavirus antigens. The experiments confirmed that recombinant VP1 VLP-based ELISAs predominantly detected BKPyV type-specific antibodies. The results imply that anti-BKPyV antibody ELISA tests should contain a mixture of subtype-specific VLP-based antigens instead of antigen derived from the most prevalent BKPyV-I subtype. The tests can be used for serological surveys of BKPyV infection and improved KTx patient management.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30102 - Immunology
Result continuities
Project
<a href="/en/project/TH01010548" target="_blank" >TH01010548: New materials and technologies for diagnostics od polyomaviruses in immunodeficient patients.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of medical virology
ISSN
0146-6615
e-ISSN
—
Volume of the periodical
91
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
856-864
UT code for WoS article
000460471800018
EID of the result in the Scopus database
2-s2.0-85060146141